_edited.png)
Synfinite Labs Appoints Andrew Wells as New Sales Director
Fast Facts
Who / Where: Synfinite Labs (formerly The Terpene Store), based in Northridge, California, appoints Andrew Wells as Director of Sales.
What changed: Andrew Wells has been hired as Director of Sales to spearhead revenue strategy, customer engagement, and commercial expansion following the company's corporate rebranding.
Effective / Key date: October 20, 2026
Status: Executive appointment is active immediately as Synfinite Labs enhances its B2B sales infrastructure across domestic and international markets.
DMV impact: Synfinite Labs provides strain-specific botanical and cannabis-derived terpene profiles to processors, vape manufacturers, and delivery services in Washington DC, Maryland, and Virginia.
The bottom line: As of October 20, 2026, Synfinite Labs, a pioneer in terpene and flavor systems, has appointed Andrew Wells as Director of Sales. Wells will lead revenue strategy and commercial growth for the company, which supplies precision strain profiles and innovative formulation technologies to vape, concentrate, and pre-roll manufacturers across the U.S. and internationally.
The specialized supply chain propelling modern cannabis manufacturing is evolving rapidly. A significant transition was reported by mg Magazine – Premier B2B Cannabis Magazine | Trusted Cannabis News, highlighting Synfinite Labs's strategic appointment of Andrew Wells as its new Director of Sales. In this new role, Wells will oversee revenue strategies, client acquisition, and global growth as the company accelerates its business following its rebranding.
Previously known as The Terpene Store, Synfinite Labs has established itself as a vital player in the B2B cannabis ecosystem. The company specializes in formulating precision strain profiles, botanical terpene blends, cannabis-derived terpene (CDT) systems, and customized flavor matrices used by producers of vape cartridges, concentrates, and pre-rolls. As cannabis processing labs prioritize product consistency and unique consumer experiences, standardized terpene formulations are becoming indispensable assets for brand scaling.
For cannabis brands operating in the Mid-Atlantic area—where robust retail markets in Maryland and evolving structures in Virginia necessitate reliable and compliant wholesale inputs—the enhancement of B2B supply chains is critical. These developments directly influence product quality, shelf performance, and operational profitability. Understanding how significant executive transitions at major B2B suppliers affect the broader cannabis delivery ecosystem is essential for entrepreneurs and investors alike.
What Does Andrew Wells Bring to Synfinite Labs as Director of Sales?
Andrew Wells brings a wealth of executive sales, branding, and operational experience to Synfinite Labs. His previous role as the head of sales and chief of staff at Y Combinator-backed Sorting Robotics saw him focus on driving commercial growth, enhancing brand partnerships, and scaling sales infrastructures.
Before his tenure at Sorting Robotics, Wells accrued significant experience in both commercial cannabis and mainstream consumer goods. He served as Chief Brand Officer at Rise Co-Packing and Jiko Joints, gaining deep insights into high-volume manufacturing, contract packaging, and pre-roll production. Additionally, he co-founded Lauren B. Beauty and served as COO, expanding the cosmetic brand's international distribution into over 15 countries.
Wells’ academic background combines hard science with advanced business administration. He holds a Bachelor of Science in cellular and molecular biology from Pepperdine University and an MBA from Benedictine University, along with ongoing studies in Harvard Business School's Program for Leadership Development. This convergence of a scientific foundation with corporate leadership experience is perfectly suited to Synfinite's intricate botanical formulation catalog and technically demanding product architecture.
The Science and Scale Behind Synfinite Labs
Founded in 2015 by Mike Schneider, Synfinite Labs, initially known as The Terpene Store, has evolved from a pioneering terpene blending enterprise to a sophisticated flavor systems manufacturer, now servicing hundreds of licensed cannabis and hemp brands across all legal states and various international markets.
Central to Synfinite's manufacturing capabilities is its custom-engineered 13,000-square-foot facility in Northridge, California. Operating under strict ISO 9001 certification, the facility ensures unparalleled batch-to-batch consistency, chemical safety, and stringent quality assurance controls. The firm boasts an expansive library of more than 300 third-party-tested formulations, offering strain-specific profiles along with customized aroma and flavor solutions tailored for both vaporizers and infused flower applications.
Terpenes are the primary aromatic compounds that lend distinct scent, flavor, and sensory attributes to individual cannabis cultivars. In modern manufacturing, standardized terpene profiles enable brand owners to consistently replicate sensory experiences across large-scale production runs, even amidst variable biomass inputs. By pairing certified manufacturing facilities with third-party analytical testing, suppliers like Synfinite ensure processors meet both legal requirements and consistency standards necessary for large-scale distribution.
How Do Terpene Supply Chains Impact the Cannabis Delivery Business Model?
Terpene supply chains have a direct impact on the cannabis delivery business model by influencing product shelf life, flavor consistency, and profit margins for vape cartridges, pre-rolls, and concentrates distributed through courier services. High-grade terpene formulations help licensed delivery services and dispensaries maintain inventory quality throughout the transit and storage processes.
In competitive retail landscapes, customer retention largely depends on product reliability. Whether a consumer orders via a dispensary delivery app in Washington DC or purchases through licensed retailers in Maryland, they expect consistent flavor profiles and psychoactive effects with each repeat order. Standardized terpene formulations allow infused flower producers, concentrate labs, and pre-roll manufacturers to ensure dependable sensory experiences, thus reducing return rates and diminishing customer churn for marijuana courier services.
Moreover, dependable terpene inputs can significantly enhance a marijuana courier service's profit margins by encouraging higher-margin product offerings. Infused pre-rolls, flavor-differentiated vape cartridges, and specialized botanical extracts can command premium prices per gram compared to raw, uninfused flower. As delivery operators streamline their inventory turn rates and unit economics, stocking high-quality infused products based on stable, batch-tested terpene systems delivers superior revenue per delivery.
Executive and Operational Summary: Synfinite Labs Leadership Transition
Operational Category | Foundational State | Current Synfinite Capability | Strategic Growth Directive |
|---|---|---|---|
Facility & Infrastructure | Early formulation lab (2015) | 13,000 sq ft ISO 9001 facility (Northridge, CA) | Scale worldwide enterprise distribution |
Product Library | Initial terpene profiles | 300+ third-party-tested formulations | Expand custom profiles for vapes & infused flower |
Sales Leadership | Founder-led growth (Mike Schneider) | Andrew Wells (Director of Sales) | Build national sales infrastructure & brand partnerships |
Market Reach | Regional B2B customers | Hundreds of brands across all legal states | Penetrate emerging state markets & global trade |
Market Impact Analysis
The strategic appointment of experienced executive sales leaders at terpene formulation companies signals a notable maturation in the legal cannabis B2B landscape. As state markets transition from the initial retail gold rush to a structured consumer packaged goods (CPG) framework, commercial power is shifting towards infrastructure providers, flavor houses, automated processing engineers, and specialized logistics networks.
For investors eyeing cannabis delivery opportunities and wider market equities, the stability of secondary supply chain operators is a critical factor. Companies that offer asset-light or specifically-targeted formulation technologies escape many of the tax burdens that hit plant-touching operations (including federal tax code 280E limitations) while maintaining robust gross margins and recurring nationwide B2B sales cycles. As brands extend their reach via licensing agreements across multiple states, consistent terpene formulations allow operators to replicate signature strains without transporting plant material over state lines.
From an economic perspective, the evolution of standardized flavor matrices leads to reduced manufacturing costs for processing labs. By utilizing established libraries of third-party-tested terpenes, vape cartridge manufacturers can simplify internal chemical testing and formulation efforts, accelerating their time to market. This efficiency is critical for maintaining revenue from cannabis delivery apps, where quick inventory turnover is dependent on processing labs securing steady, reliable supplies of popular SKUs.
Business Opportunities for DMV Entrepreneurs
The ongoing evolution in upstream cannabis technology is generating actionable chances for entrepreneurs, processors, and delivery operators across Washington DC, Maryland, and Virginia. Each jurisdiction within the DMV boasts distinct market dynamics where terpene-enhanced products and targeted distribution strategies can create significant competitive advantages.
In Virginia, current legislation permits personal adult use and cultivation while the state continues refining its framework for commercial retail and delivery. Understanding successful cannabis business models in neighboring legal states can greatly aid Virginia entrepreneurs as they prepare for operational plans aligned with future legal retail structures. As rules progress, processors leveraging certified B2B terpene profiles can develop compliant product lines that resonate with regional consumer preferences.
In Maryland, with adult-use retail and medical sales operating concurrently, licensed processors depend heavily on certified terpene suppliers to develop distinct pre-rolls and strain-specific vape cartridges. Delivery operators catering to Maryland's medical and adult users stand to benefit from sourcing stable SKUs that minimize degradation during transit. In Washington DC, where medical dispensaries and delivery services cater to a diverse urban population, offering popular concentrates and uniquely flavored vapes enables operators to differentiate in a saturated market.
Investment Considerations and Risks
While B2B supply chains present lucrative commercial potential, investors and delivery operators must navigate inherent industry risks and regulatory challenges. Success in cannabis delivery investments and manufacturing necessitates stringent risk management relating to product compliance, legal jurisdiction boundaries, and inventory control.
A key risk revolves around understanding the legal differences between botanical terpenes derived from non-cannabis plants and cannabis-derived terpenes sourced from legal cannabis material. While botanical terpenes are fully legal for interstate commerce, cannabis-derived ones face a complex web of regulations varying by state and bans on interstate transport. Processing labs and delivery brands must ensure uncompromising compliance regarding labeling and raw material sourcing in every target market.
Furthermore, operational risks for delivery services include managing heat exposure, oxidation, and packaging integrity during transit. Terpenes are volatile organic compounds that deteriorate fast when subjected to heat or sunlight. As a result, delivery networks must invest in temperature-controlled transport and appropriate storage protocols to maintain product flavor and potency, thereby preserving brand integrity and avoiding costly inventory losses.
Bud Lords Take: Scaling Quality and Consistency in DMV Supply Chains
Bud Lords Take: We believe that the professionalization of wholesale formulation processes is a fundamental enhancement for delivering customers and artisanal producers throughout DC, Maryland, and Virginia. For too long, early cannabis markets suffered from inconsistent vape flavors, defective pre-roll infusions, and erratic batch quality. When notable terpene manufacturers implement ISO 9001-certified production facilities and recruit seasoned executive talent, this elevates the standards across the entire supply chain.
Our firsthand experience catering to regional cannabis customers shows that quality and reliability are what convert first-time delivery users into repeat loyal clients. Whether a user is ordering high-end pre-rolls, live rosin concentrates, or distillate vape pens, they deserve nothing less than clean, third-party-tested goods featuring accurate terpene profiles. As industry leaders set high operational benchmarks, small-batch producers and local delivery services can tap into top-tier formulation technologies, leveling the competitive landscape against large corporate multi-state operators (MSOs).
The Future of Cannabis Formulation and Regional Delivery Networks
With Andrew Wells taking the helm at Synfinite Labs, the convergence of cutting-edge botanical formulation, advanced automation, and specialized sales strategies will continue shaping the future of the legal cannabis market. For brands looking to penetrate emerging legal frameworks along the East Coast, dependable B2B supply partnerships are essential in ensuring consistent access to specifications and technical support.
For entrepreneurs, delivery service founders, and investors watching the Mid-Atlantic market, paying close attention to B2B infrastructure developments offers vital insights into consumer product trajectories. As advancements in terpene science open doors to specialized cannabinoid-terpene synergistic formulations, operators integrating high-purity, standardized inputs into their delivery offerings are poised to capture robust commercial growth in the years ahead.
Have a cannabis story, local update, or strain you want our newsroom to cover? Request a story →
Written by The People's AI
Bud Lords AI Cannabis News Writer
Community-focused AI that creates content based on user suggestions and comments. Acknowledges user contributions, asks engaging questions, and builds content around what the community actually wants to discuss. Uses collaborative language like "Based on your suggestion...
Expertise: community-driven · user-suggestions · trending-topics · community-engagement · user-feedback
This AI-assisted article was created using the named Bud Lords newsroom personality and reviewed under Bud Lords editorial standards.
Comments